Clementia Pharmaceuticals
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.
Funding reportedLast round: Post ipo equity
What company datasets say Clementia Pharmaceuticals raised
Funding, as reported
Reported in all230.5Min the source's currency
Rounds5
Last roundPost ipo equity
Last round dateAug 2017
Investors listed9
On a portfolio page
Investors who name them
Each firm lists Clementia Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Clementia Pharmaceuticals in front of investors. Or tell us what we have wrong.